Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Solvonis Therap (SVNS) Share Price

Price 0.215p on 27-06-2025 at 18:50:08
Change 0.025p 13.16%
Buy 0.22p
Sell 0.21p
Buy / Sell SVNS Shares
Last Trade: Unknown 21,900,928.00 at 0.222p
Day's Volume: 201,223,805
Last Close: 0.215p
Open: 0.195p
ISIN: GB00BMD1Z199
Day's Range 0.20p - 0.235p
52wk Range: 0.087p - 0.45p
Market Capitalisation: £17m
VWAP: 0.214598p
Shares in Issue: 7,983m

Solvonis Therap (SVNS) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 21,900,928 0.222p Ordinary
16:45:51 - 27-Jun-25
Buy* 1,082,790 0.22p Ordinary
16:25:05 - 27-Jun-25
Buy* 2,500,000 0.2199p Ordinary
16:18:36 - 27-Jun-25
Sell* 420,030 0.2125p Ordinary
16:16:03 - 27-Jun-25
Buy* 2,000,000 0.2175p Ordinary
16:09:47 - 27-Jun-25
Buy* 5,000 0.23p SI Trade
16:09:08 - 27-Jun-25
Buy* 10,000 0.23p SI Trade
16:09:08 - 27-Jun-25
Buy* 12,000 0.23p SI Trade
16:09:08 - 27-Jun-25
Buy* 6,000 0.23p SI Trade
16:09:08 - 27-Jun-25
Buy* 7,000 0.23p SI Trade
16:09:08 - 27-Jun-25
See more Solvonis Therap trades

Solvonis Therap (SVNS) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Jun 2025 (Fri) 0.195 0.235 0.20 0.215 201,223,805
26th Jun 2025 (Thu) 0.18 0.195 0.18 0.19 87,736,116
25th Jun 2025 (Wed) 0.18 0.18 0.18 0.18 40,088,697
24th Jun 2025 (Tue) 0.19 0.19 0.18 0.18 31,608,019
23rd Jun 2025 (Mon) 0.18 0.205 0.175 0.19 121,498,494
20th Jun 2025 (Fri) 0.175 0.1735 0.1735 0.1735 64,075,464
19th Jun 2025 (Thu) 0.18 0.175 0.173 0.175 77,881,995
18th Jun 2025 (Wed) 0.19 0.19 0.18 0.18 31,714,610
17th Jun 2025 (Tue) 0.20 0.20 0.185 0.19 57,085,747
16th Jun 2025 (Mon) 0.19 0.208 0.208 0.208 406,793,855
13th Jun 2025 (Fri) 0.19 0.20 0.185 0.19 98,659,245
12th Jun 2025 (Thu) 0.1725 0.195 0.1725 0.19 182,502,603
11th Jun 2025 (Wed) 0.1675 0.18 0.165 0.1725 320,895,798
10th Jun 2025 (Tue) 0.145 0.1625 0.145 0.1625 124,555,044
9th Jun 2025 (Mon) 0.1425 0.145 0.1425 0.145 129,567,023
6th Jun 2025 (Fri) 0.135 0.145 0.14 0.1425 137,144,498
5th Jun 2025 (Thu) 0.135 0.135 0.135 0.135 52,459,340
4th Jun 2025 (Wed) 0.135 0.135 0.135 0.135 16,974,603
3rd Jun 2025 (Tue) 0.1325 0.13 0.13 0.13 187,375,516
2nd Jun 2025 (Mon) 0.1325 0.1325 0.1325 0.1325 23,663,449
30th May 2025 (Fri) 0.1325 0.136 0.136 0.1325 21,263,522
29th May 2025 (Thu) 0.135 0.135 0.1325 0.1325 23,892,558
See more Solvonis Therap price history

Solvonis Therap (SVNS) Regulatory News

Date Source Headline
27th Jun 2025 2:38 pm RNS AGM Statement
27th Jun 2025 8:54 am RNS Holding(s) in Company
26th Jun 2025 10:21 am RNS-R Initiation of Research Coverage
23rd Jun 2025 7:00 am RNS Allowance of U.S. patent covering AI-supported CNS
11th Jun 2025 7:30 am RNS Initiation of AI supported CNS drug discovery
5th Jun 2025 7:00 am RNS Synthesis of development candidate for SVN-SDN-014
3rd Jun 2025 4:30 pm RNS Notice of Annual General Meeting
3rd Jun 2025 7:00 am RNS Appointment of Prof. David Nutt as CSO
2nd Jun 2025 11:58 am RNS Holding(s) in Company
30th May 2025 5:00 pm RNS Total Voting Rights
See more Solvonis Therap regulatory news

Solvonis Therap (SVNS) Share News

Solvonis granted US patent for AI-led CNS compound programme

23rd Jun 2025 11:12

(Alliance News) - Solvonis Therapeutics PLC on Monday said the US Patent & Trademark Office has allowed a core patent application covering compounds in its artificial-intelligence-enabled central-nervous-system discovery programme, granting protection in the US's drug market for at least 18 years. Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2025 12:02

Read More

TRADING UPDATES: Ten Lifestyle celebrates new Japan contract win

11th Jun 2025 22:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Solvonis promotes Professor David Nutt to chief scientific officer

3rd Jun 2025 14:02

(Alliance News) - Solvonis Therapeutics PLC on Tuesday announced the appointment of neuroscience professor David Nutt as its chief scientific officer, with immediate effect. Read More

TRADING UPDATES: T42 IOT Tracking extends CLN repayment dates

16th May 2025 21:51

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

See more Solvonis Therap news
FTSE 100 Latest
Value8,798.91
Change63.31

Login to your account

Forgot Password?

Not Registered